Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less ...

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue ...

Glioblastoma, an aggressive brain cancer, has a very poor prognosis.  More than 95% of glioblastoma patients die within five ...

Researchers have developed a promising CAR-T cell therapy targeting glioblastoma, the most aggressive brain tumor.

Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis.

From a recent study by Mayo Clinic, discover how preoperative radiotherapy could improve survival rates for glioblastoma ...

Researchers have discovered that the antidepressant vortioxetine effectively combats glioblastoma, a deadly brain tumor, in ...

Glioblastoma is a brain cancer with very poor survival outcomes. Most drugs can't cross the blood-brain barrier, which means ...

Glioblastoma is a particularly aggressive brain tumour that at present is incurable. Cancer doctors can extend patients' life ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.

Allen R. “Rick” Vornadore, a homebuilder and founder and president of Van Allen Homes, died Sept. 7 at Gilchrist Center in ...